GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

Elena López‐Isac(Instituto de Parasitología y Biomedicina "López - Neyra"), Marialbert Acosta‐Herrera(Instituto de Parasitología y Biomedicina "López - Neyra"), Martin Kerick(Instituto de Parasitología y Biomedicina "López - Neyra"), Shervin Assassi(The University of Texas Health Science Center at Houston), Ansuman T. Satpathy(Howard Hughes Medical Institute), Jeffrey M. Granja(Howard Hughes Medical Institute), Maxwell R. Mumbach(Howard Hughes Medical Institute), Lorenzo Beretta(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Carmen Pilar Simeón‐Aznar(Vall d'Hebron Hospital Universitari), Patrícia Carreira(Research Institute Hospital 12 de Octubre), Norberto Ortego‐Centeno(Instituto de Investigación Biosanitaria de Granada), I. Castellví(Hospital de Sant Pau), Lara Bossini‐Castillo(Wellcome Sanger Institute), F. David Carmona(Universidad de Granada), Gisela Orozco(Manchester Academic Health Science Centre), Nicolas Hunzelmann(University of Cologne), Jörg H. W. Distler(Friedrich-Alexander-Universität Erlangen-Nürnberg), André Franke(Christian-Albrechts-Universität zu Kiel), Claudio Lunardi(University of Verona), Gianluca Moroncini(Marche Polytechnic University), Armando Gabrielli(Marche Polytechnic University), Jeska de Vries‐Bouwstra(Leiden University Medical Center), Cisca Wijmenga(University Medical Center Groningen), Bobby P. C. Koeleman(University Medical Center Utrecht), Annika Nordin(Karolinska University Hospital), Leonid Padyukov(Karolinska University Hospital), Anna‐Maria Hoffmann‐Vold(Oslo University Hospital), Benedicte A. Lie(Oslo University Hospital), European Scleroderma Group†(Instituto de Investigación Biosanitaria de Granada), Raimon Rios(Instituto de Investigación Biosanitaria de Granada), José Luís Callejas-Rubio(Instituto de Investigación Biosanitaria de Granada), José Antonio Vargas‐Hitos(Hospital Universitario Virgen de las Nieves), Rosa García-Portales(Hospital Doctor José Molina Orosa), M T Camps(Hospital Doctor José Molina Orosa), Antonio Fernández‐Nebro(Hospital Doctor José Molina Orosa), Marı́a-Francisca González-Escribano(Hospital Universitario Virgen del Rocío), Francisco José García Hernández(Hospital Universitario Virgen del Rocío), María Jesús Castillo(Instituto Maimónides de Investigación Biomédica de Córdoba), M. Á. Aguirre(Instituto Maimónides de Investigación Biomédica de Córdoba), Inmaculada Gómez-Gracia(Hospital Clínico San Carlos), Benjamín Fernández‐Gutiérrez(Hospital Clínico San Carlos), Luis Rodríguez‐Rodríguez(Hospital Clínico San Carlos), Paloma García de la Peña(Hospital Universitario de La Princesa), Esther Vicente(Hospital Universitario Puerta de Hierro Majadahonda), José Luís Andreu(Hospital Universitario Puerta de Hierro Majadahonda), M. Fernández Castro(Hospital General Universitario Gregorio Marañón), Francisco Javier López-Longo(Hospital General Universitario Gregorio Marañón), Leticia Quintanilla Martinez(Hospital General Universitario Gregorio Marañón), Fonollosa(Vall d'Hebron Hospital Universitari), Alberto Guillén(Hospital Clínic de Barcelona), Gerard Espinosa(Hospital Clínic de Barcelona), Carlos Tolosa(Hospital Del Mar), A. Pros(Mútua Terrassa), Mónica Rodríguez‐Carballeira(Bellvitge University Hospital), Javier Narváez(Bellvitge University Hospital), Manuel Rubio‐Rivas(Bellvitge University Hospital), Ortiz-Santamaría(Hospital General San Jorge), Ana Belén Madroñero(Universidad de Cantabria), Miguel Á. González‐Gay(Universidad de Cantabria), Bianca J. Diaz(Hospital Universitario Central de Asturias), Luis Trapiella(University Hospital Complex Of Vigo), André M. M. Sousa(University Hospital Complex Of Vigo), M. V. Egurbide(Hospital de Cruces), P. Fanlo-Mateo(Hospital Universitario Miguel Servet), Luís Sáez-Comet(Hospital Universitario de Canarias), Fidel Díez Díaz(Hospital Universitario de Canarias), Hernández(Hospital General Universitario De Valencia), E. Beltrán(Hospital Universitari i Politècnic La Fe), José Andrés Román-Ivorra(Hospital Universitari i Politècnic La Fe), Elena Grau(Hospital Universitari i Politècnic La Fe), Juan José Alegre Sancho(University Hospital Complex Of Vigo), M. Freire(University Hospital Complex Of Vigo), Francisco J. Blanco(Complexo Hospitalario Universitario A Coruña), N. Oreiro(Medizinische Hochschule Hannover), Torsten Witte(Medizinische Hochschule Hannover), Alexander Kreuter(St. Josef-Hospital), G. Riemekasten(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Paolo Airó(Leiden University Medical Center), C. Magro(Leiden University Medical Center), Alexandre E. Voskuyl(Radboud University Nijmegen), M. C. Vonk(Radboud University Nijmegen), Roger Hesselstrand(Royal Adelaide Hospital), Susanna Proudman(Royal Adelaide Hospital), Wendy Stevens(The University of Melbourne), Mandana Nikpour(University of Tasmania), Australian Scleroderma Interest Group (ASIG)(Monash Medical Centre), Jane Zochling(University of Tasmania), J. Sahhar(Monash Medical Centre), Janet Roddy(Royal Perth Hospital), Peter Nash(Queen Elizabeth Hospital), Kathleen Tymms(Queen Elizabeth Hospital), Maureen Rischmueller(King's College London), Sue Lester(Queen Elizabeth Hospital), Timothy J. Vyse(King's College London), Ariane L. Herrick(Manchester Academic Health Science Centre), Jane Worthington(Délégation Paris 5), Christopher P. Denton(Translational Research Institute), Yannick Allanore(Délégation Paris 5), Matthew A. Brown(Translational Research Institute), Timothy R. D. J. Radstake(Howard Hughes Medical Institute), Carmen Fonseca(The Royal Free Hospital), Howard Y. Chang(Howard Hughes Medical Institute), Maureen D. Mayes(The University of Texas Health Science Center at Houston), Javier Martı́n(Instituto de Parasitología y Biomedicina "López - Neyra")
Nature Communications
October 31, 2019
Cited by 184Open Access
Full Text

Abstract

Systemic sclerosis (SSc) is an autoimmune disease that shows one of the highest mortality rates among rheumatic diseases. We perform a large genome-wide association study (GWAS), and meta-analysis with previous GWASs, in 26,679 individuals and identify 27 independent genome-wide associated signals, including 13 new risk loci. The novel associations nearly double the number of genome-wide hits reported for SSc thus far. We define 95% credible sets of less than 5 likely causal variants in 12 loci. Additionally, we identify specific SSc subtype-associated signals. Functional analysis of high-priority variants shows the potential function of SSc signals, with the identification of 43 robust target genes through HiChIP. Our results point towards molecular pathways potentially involved in vasculopathy and fibrosis, two main hallmarks in SSc, and highlight the spectrum of critical cell types for the disease. This work supports a better understanding of the genetic basis of SSc and provides directions for future functional experiments.


Related Papers

No related papers found

Powered by citation graph analysis